March 9th 2025
Exosomes, polymeric nanoparticles, and DNA nanostructures offer many potential advantages.
Astellas and Ambrx Collaborate on Antibody Drug Conjugates for Oncology
April 8th 2013Astellas and Ambrx have entered into a collaboration to discover and develop novel antibody drug conjugates (ADCs) for an undisclosed number of targets in oncology. ADCs enable targeted delivery of drugs to the target tissue.